Background : Dengue is a mosquito-borne (Ades Agepti) infection which in recent years has become a major public health problem. It is now endemic in more than 100 countries in Africa, America, Eastern Mediterranean, South-East Asia and Western Pacific areas. According to WHO currently approximately 50 million cases of dengue fever occur every year.
Introduction
Dengue fever is a self-limiting, systemic viral illness caused by several arthropod-borne viruses. Symptomatic dengue virus infections can present with a wide range of clinical manifestations, from mild febrile illness to a lifethreating shock syndrome. It is characterized by biphasic fever, myalgia or arthralgia, rash, leukopenia and lymphadenopathy. It may increase capillary permeability. There is hemostatic abnormality, and in severe case, a protein-losing shock syndrome (dengue shock syndrome), which is thought to have an immune pathologic basis. 1 Over the past three decades, globally, there has been a dramatic increase in the frequency of Dengue fever (DF), dengue hemorrhagic fever(DHF) and dengue shock syndrome (DSS).Approximately 2.5 billion people around the world live in dengue endemic countries of which 1.3 billion live in 10 countries of the South-East Asia Region which are dengue endemic area. 2 An estimated 50 million infections including 250000-500000 cases of dengue haemorrhagic fever and 24000 deaths per year occur across approximately 100countries.Approximately 500000 cases of DHF require hospitalization each year of whom a very large proportion are children and among them roughly 5% die. Nearly 90% of the dengue infections occur in children with a risk of dying during a second attack which is nearly 15-fold higher than that of adults. The management of dengue is essentially supportive. Without proper treatment, DHF-case-fatality rates can exceed 20%. With modern intensive supportive therapy, the rate can be reduced to less than 1%. 3 In Bangladesh, thefirst documented case of dengue-like fever occurred in 1964 popularly known as "Dacca fever" which later on serologically proved as dengue fever. 4 The The objectives ofthis study were to know the demographic profile, clinicalfeatures, serology and outcome of dengue patients admitted at Dhaka Shishu (Children) Hospital.
Methodology :
This study was a prospective observational study carried out on suspected dengue fever patients who were admitted at Dhaka Shishu (Children) Hospital, during the period of June to December 2016. Children were 1 year to 18 years of age. After obtaining informed consent from the parents, a total of 78 children suspected dengue fever (based on clinical features) were primarily enrolled for this study. Patient with any identified specific infection or febrile illness more than 14 days and serologically dengue negative cases were excluded from the study.
Fifty six (56) serologically positive (NS1 antigen, IgM, IgG antibodies) dengue patients were finally selected for our study. Dengue serology (Rapid qualitative immune-chromatographic test -NS 1 antigen was done in patients who presented with fever for 3 days or of lesser duration and Dengue IgM and IgG were done in those who came with fever for more than 5 days. Table I . fig. 2 ). The age of the children range from 1 year to 18 years with a mean age of 6.66 ±3.69 years. The age distribution of the patients are shown in Table II . The number of the patients increased progressively from June to maximum in the month of September and then declined. The monthly distribution of the dengue patients is shown in figure 3. Outcome of the disease were 89.3% discharge with advice (DA), 7.1% discharge on request (DOR), 3.6% left against medical advice (LAMA) and no death (table VI) . 
Discussion
In the present study, among 78 suspected dengue cases 56 (71.8%) cases were serologically dengue positive. Therefore these serologically dengue positive cases were selected for our study. July 2017 n Volume 9 n Number 1 277
respectively and both positive in 31% cases). 5 In the present study, the majority of the patients (46.4%) belong to the 1 years to 18 years age group with a male (55.44%) preponderance. Sarker et al 6 (2012) The majority of the patients were urban residents, this might be due to the location of the hospitals in the urban areas, additionally, urbanization also favors vector breeding.
In our study we found that the number of the dengue patients increased progressively from the month of June to maximum in the month of September and then declined. The majority of the patients were reported during monsoon and post-monsoon seasons, in accordance with the earlier reports of the dengue transmission.
10
The common presenting features of the patients were fever (100% In our study the rashes were 55.35% which was much lesser than that of Shahidul ABM et al (2009) and it was 75.9%.
11
In the present study the mean platelet count of the patients was 94333/mm 3 which was below 1,00,000/mm. 3 The mean PCV was found 35% and the mean SGPT was 210 U/L. These findings were all similar to the observations of Shahidul ABM et al(2009). 5 There was no mortality in our study whereas it was 3.8% in Agarwal et al study (1996) , 10.91% in Wali et al study (1997), 3.8% in Rahim et al study (2006) and 6% in ABM Shahidul ABM et al study (2009). 5, [12] [13] [14] In our study, DSS was a rare event,
resulting in a lower case-fatality rate for dengue than reported elsewhere.
Conclusion
Inour observation the incidence of dengue was more in male child, peak age group was being 6 years to 12 years with most admissions during the month of September. Fever with pain (body ache, retro orbital pain), headache and maculopapular rash, positive NS 1 Ag, dengue IgM were the main findings found in children with dengue. Most of the dengue cases were DF and DHF-l in our study.
